• info@platform-residras.com

International Registry of Dravet Syndrome and other Syndromes correlated with genes on SCN1A and PCDH19

Caregiver impact and health service use in high and low severity Dravet syndrome: A multinational... https://www.seizure-journal.com/article/S1059-1311(18)30621-6/fulltext
Dravet syndrome (DS) is a rare and complex developmental encephalopathy characterised by refractory epilepsy, motor and cognitive impairments, and behavioural disorders (such as attention/hyperactivity symptoms, autistic traits, conduct problems and problems with peer relationships) [1–3]. Familie...
Dravet Syndrome Foundation Exciting update from Stoke at this year's American Epilepsy Society (AES) meeting. DSF was thrilled to have Dr. Lori Isom share an update with our professional community at our 9th annual Research Roundtable.
Pubblication around Dravet Syndrome and Drug Resistant ...
Ovid Therapeutics Inc. Today, we’re excited to share that we plan to move ahead into a Phase 3 trial in children aged 4 to 12 with Angelman syndrome in the second half of 2019. Learn more about our news: https://bit.ly/2SuvJZK
Pubblication around Dravet ...
EPIDIOLEX® (cannabidiol) Oral Solution – the First FDA-approved Plant-derived Cannabinoid Medicine – Now Available by... The Investor Relations website contains information about GW Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
Dravet Syndrome Foundation What is Dravet syndrome? #EpilepsyAwarenessMonth
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared Dravet Syndrome Foundation's post.
Zogenix Provides Corporate Update and Reports Third Quarter Financial Results | Zogenix, Inc The Investor Relations website contains information about Zogenix, Inc's business for stockholders, potential investors, and financial analysts.
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis Background Approximately one-third of patients with epilepsy presents seizures despite adequate treatment. Hence, there is the need to search for new therapeutic options. Cannabidiol (CBD) is a major...
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
Cannabis and epilepsy. - PubMed - NCBI https://www.ncbi.nlm.nih.gov/pubmed/30337476
Pract Neurol. 2018 Oct 18. pii: practneurol-2018-002058. doi: 10.1136/practneurol-2018-002058. [Epub ahead of print]

Load More